USPTO Examiner BEISNER WILLIAM H - Art Unit 1799

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18829031BIOREACTOR EXHAUST SYSTEMSeptember 2024February 2025Allow510YesNo
18813810SYSTEMS AND METHODS FOR MAINTAINING ORGAN PRESSUREAugust 2024April 2025Allow810NoNo
18705278CELL CULTURE SYSTEM WITH CONTROLLED GAS TRANSFER BOUNDARY CONDITIONSApril 2024June 2025Allow1400NoNo
18606045THERMAL CYCLER SYSTEMS AND METHODS OF USEMarch 2024May 2025Allow1420NoNo
18689180CHARGE-SENSITIVE OPTICAL DETECTION OF BINDING KINETICS BETWEEN PHAGE DISPLAYED PEPTIDE LIGANDS AND PROTEIN TARGETSMarch 2024November 2024Allow810YesNo
18442661MULTI-WELL SAMPLE TESTING APPARATUS AND METHODS OF SAMPLE TESTING USING THE SAMEFebruary 2024June 2025Allow1620NoNo
18409771BIO-GROWTH CHAMBER WITH ROTARY MOTION AND HEATING SYSTEM AND RELATED METHODSJanuary 2024July 2024Allow610NoNo
18406708REACTOR HAVING DYNAMIC SPARGERJanuary 2024December 2024Allow1210YesNo
18484728Lung Disease Models On A ChipOctober 2023December 2024Allow1510NoNo
18374435SYSTEMS AND DEVICES FOR PRODUCING BIOLOGICAL PRODUCTS AND METHODS OF USING THE SAMESeptember 2023September 2024Allow1220YesNo
18472301APPARATUS AND METHOD FOR ISOLATING STEM CELLSSeptember 2023October 2024Allow1310NoNo
18348680CONVERTING GASEOUS CARBON COMPOUNDS TO CARBON NEUTRAL OR NEGATIVE PRODUCTSJuly 2023January 2025Allow1821YesNo
18219266CELL CULTURE VESSELS WITH STABILIZER DEVICESJuly 2023October 2024Allow1511NoNo
18215105ELECTROPORATIONJune 2023December 2024Abandon1820NoNo
18340420APPARATUS TO SIMULATE BIOCIDE PERFORMANCE IN CRUDE PIPELINE CONDITIONSJune 2023June 2024Allow1210NoNo
18213126SYSTEM AND METHOD FOR DETERMINING A FORCE APPLIED TO OR GENERATED BY A CELL OR TISSUE CULTUREJune 2023May 2025Allow2220NoNo
18203767METHOD FOR REMEDIATING PETROLEUM HYDROCARBON CONTAMINATION IN GROUNDWATERMay 2023November 2023Allow610NoNo
18119195REAL TIME ELECTRONIC CELL SENSING SYSTEMS AND APPLICATIONS FOR CELL-BASED ASSAYSMarch 2023September 2024Abandon1920NoNo
18096851PHOTOSYNTHETIC BIOREACTOR FOR THE CONVERSION OF ELECTRICITY AND FERTILIZER INTO BIOMASSJanuary 2023April 2024Allow1510YesNo
18096671CAPILLARY ASSISTED VITRIFICATION PROCESSES AND DEVICESJanuary 2023June 2024Allow1710NoNo
18095402REAL TIME ELECTRONIC CELL SENSING SYSTEMS AND APPLICATIONS FOR CELL-BASED ASSAYSJanuary 2023June 2024Abandon1720NoNo
18148139THERMAL CYCLER SYSTEMS AND METHODS OF USEDecember 2022November 2023Allow1110NoNo
17999445DEVICE, METHOD AND COMPOSITION FOR TRANSFECTION OF CELLS WITH NUCLEIC ACIDSNovember 2022March 2025Allow2831NoNo
17989935DEACETYLATION AND CROSSLINKING OF CHITIN AND CHITOSAN IN FUNGAL MATERIALS AND THEIR COMPOSITES FOR TUNABLE PROPERTIESNovember 2022October 2024Abandon2311NoNo
18051295REACTOR HAVING DYNAMIC SPARGEROctober 2022October 2023Allow2111NoNo
17966372METHODS AND MATERIALS FOR CULTIVATION AND/OR PROPAGATION OF A PHOTOSYNTHETIC ORGANISMOctober 2022October 2024Abandon2420YesNo
17878508MULTI-ORGAN REPAIRING AND TRANSFERRING DEVICE WITHOUT INTERRUPTING BLOOD FLOWAugust 2022January 2023Allow620NoNo
17854303CELL CULTURE SYSTEMJune 2022August 2023Allow1411NoNo
17706569CONVERSION OF LIGNOCELLULOSIC BIOMASS INTO BIOGASMarch 2022October 2024Allow3030NoNo
17703718PORTABLE REAL-TIME AIRBORNE FUNGI ACQUIRING AND DETECTING EQUIPMENT AND METHODMarch 2022December 2022Allow801NoNo
17701045POLYLACTIDE CELL CULTURE CONTAINERS AND USE IN CELL CULTUREMarch 2022August 2023Allow1730NoNo
17762152NANOSTRAW WELL INSERT DEVICES FOR IMPROVED CELL TRANSFECTION AND VIABILITYMarch 2022May 2025Abandon3810NoNo
17753868METHOD TO INCREASE THE PERMEABILITY OF THE PLASMA MEMBRANE OF CELLS AND A STRUCTURE SUITABLE FOR USE IN SUCH METHODMarch 2022February 2025Allow3501NoNo
17670404MULTILAYERED ORGAN-ON-A-CHIP SYSTEMS AND METHODS OF USE THEREOFFebruary 2022April 2024Allow2621YesNo
17669290Device for Producing MetabolitesFebruary 2022May 2023Allow1630NoNo
17592804Reactor SystemsFebruary 2022April 2024Allow2620NoNo
17575505ISCHAEMIA-FREE ORGAN PERFUSION DEVICE AND PERFUSION METHODJanuary 2022October 2022Allow911NoNo
17564820MODULAR CONTINUOUS FLOW BIOREACTORDecember 2021April 2025Abandon3901NoNo
17596667INSTRUMENT FOR USE IN OPERATING CELLDecember 2021March 2025Allow3910NoNo
17620001CELL DISPENSING DEVICE AND CELL DISPENSING METHODDecember 2021April 2025Allow4011NoNo
17538403BIOREACTOR WITH CELL GROWTH MATRIXNovember 2021June 2023Abandon1831YesNo
17528660SYSTEM AND METHOD FOR TRANSPORTING ALGAENovember 2021March 2025Abandon4010NoNo
17519778SYSTEM, DEVICE AND METHOD FOR ELECTROPORATION OF CELLSNovember 2021February 2024Allow2820NoNo
17495765ORGAN PRESERVATION SYSTEM WITH AUTOMATIC PRIMING AND AIR REMOVALOctober 2021May 2022Allow820NoNo
17601158DEVICE FOR DETERMINING THE PRESENCE OF A BACTERIOLOGICAL CONTAMINATION IN A FLUIDOctober 2021March 2025Abandon4210NoNo
17449071ELECTROPORATION APPARATUS HAVING AN ELONGATED HOLLOWSeptember 2021July 2023Abandon2110NoNo
17474918MULTI-WELL SAMPLE TESTING APPARATUS AND METHODS OF SAMPLE TESTING USING THE SAMESeptember 2021October 2023Allow2510NoNo
17472971PERSONAL HYGIENE WIPE WITH INTEGRAL URINE GLUCOSE DETECTION FEATURESeptember 2021March 2025Abandon4210NoNo
17463597FLOW THROUGH ELECTROPORATION MODULES AND INSTRUMENTATIONSeptember 2021June 2023Abandon2110NoNo
17410060SYSTEMS AND METHODS FOR A THERMAL CYCLER HEATED COVERAugust 2021December 2023Abandon2811NoNo
17393147ARRAY PLATFORM FOR THREE-DIMENSIONAL CELL CULTURING AND DRUG TESTING AND SCREENINGAugust 2021May 2024Allow3420NoNo
173878553-DIMENSIONAL LARGE CAPACITY CELL ENCAPSULATION DEVICE ASSEMBLYJuly 2021December 2024Allow4131NoNo
17425926CELL CULTURE BOTTLEJuly 2021September 2024Allow3810NoNo
17380799Micro Flow-Through Electroporation Devices And Methods Of Cell TransfectionJuly 2021September 2024Allow3810NoNo
17378060ORGAN PRESERVATION SYSTEMJuly 2021January 2024Allow3010NoNo
17375851Cell MicroporatorJuly 2021September 2024Abandon3910NoNo
17420107A MULTI-COMPARTMENT DEVICE CONTAINING HUMAN THREE-DIMENSIONAL (3D) MICROTISSUES FOR TOXICITY TESTINGJune 2021December 2024Allow4111YesNo
17360808Preloaded DMEK HolderJune 2021December 2024Allow4220NoNo
17355901INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLSJune 2021October 2023Abandon2710NoNo
17417618HOLLOW FIBER FILTRATION SYSTEMS AND METHODSJune 2021October 2024Abandon4010NoNo
17417538CELL LYSIS WITH A MICROBEAD AND THERMAL RESISTORJune 2021March 2025Abandon4401NoNo
17417344CELL MARKING SYSTEMSJune 2021February 2025Abandon4401NoNo
173488453D PRINTED, HIGH-THROUGHPUT MICROELECTRODE ARRAYJune 2021October 2024Allow4010YesNo
17413963Intelligent Microbial Sample Treatment SystemJune 2021October 2024Allow4010NoNo
17344735MANIPULATION APPARATUS AND MANIPULATION METHODJune 2021November 2024Abandon4110NoNo
17299936BIOPHARMACEUTICAL LIQUID RESERVOIR WITH MECHANICAL MEMBER INCLUDING ROTATING AND STATIONARY SETS OF PARTSJune 2021June 2025Allow4811NoNo
17299579IMPROVED DEVICE FOR REMOVING VOLATILE ORGANIC COMPOUNDSJune 2021March 2025Allow4611NoNo
17324457VARIABLE TEMPERATURE REACTOR, HEATER AND CONTROL CIRCUIT FOR THE SAMEMay 2021December 2021Allow710YesNo
17319071ORGANISM DETECTION APPARATUSMay 2021May 2025Allow4831NoNo
17235532CULTURING APPARATUSApril 2021September 2024Abandon4110NoNo
17230669System For Propagating CellsApril 2021May 2024Abandon3720NoNo
17230196FLOW THROUGH ELECTROPORATION MODULES AND INSTRUMENTATIONApril 2021August 2021Allow410NoNo
17229301ORGAN CONTAINERApril 2021November 2024Abandon4310NoNo
17283273METHOD FOR MEMBRANE GAS TRANSFER IN HIGH DENSITY BIOREACTOR CULTUREApril 2021May 2025Allow4921NoNo
17280727CELL CULTURE BIOREACTORMarch 2021April 2025Allow4930NoNo
17213590METHOD FOR EFFICIENTLY PRODUCING � MYOSIN HEAVY CHAIN IN CARDIAC MUSCLE CELLS DIFFERENTIATED FROM INDUCED PLURIPOTENT STEM CELLS DERIVED FROM HOMO SAPIENSMarch 2021November 2024Abandon4420NoNo
17214421CELL CULTURE BIOREACTORMarch 2021March 2025Allow4821NoNo
17275900DUAL-CHAMBER VIAL FOR CORNEAL GRAFT PRESERVATIONMarch 2021August 2021Allow510YesNo
17178488Biofilm BioreactorFebruary 2021April 2024Allow3711NoNo
17175612INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLSFebruary 2021June 2021Allow410NoNo
17171403Gas Collection DeviceFebruary 2021March 2024Allow3710YesNo
17166491TISSUE PROCESSING APPARATUS AND METHOD FOR INFUSING BIOACTIVE AGENTS INTO TISSUEFebruary 2021June 2024Allow4130NoNo
17164641INTEGRATED ALGAL AND CYANOBACTERIAL PROCESS FOR BIOPRODUCT MANUFACTURINGFebruary 2021December 2023Allow3510YesNo
17158651Surface Modified Separation MediaJanuary 2021September 2024Allow4410NoNo
17155863CELL STIMULATING APPARATUS, CELL STIMULATING METHOD, CULTURE PRODUCT MANUFACTURING METHOD, ISOLATED CELL MANUFACTURING METHOD, AND CELL GROWING METHODJanuary 2021September 2022Abandon2031NoNo
17147662ELECTRICAL STIMULATION DEVICEJanuary 2021December 2023Allow3520YesNo
17259829Stacked Recirculating BioreactorJanuary 2021October 2024Allow4511YesNo
17144008SENSOR ARRAY AND APPARATUS FOR SIMULTANEOUS OBSERVATION OF TISSUE ELECTROPHYSIOLOGY, CONTRACTILITY, AND GROWTHJanuary 2021April 2024Allow4021NoNo
17247988ORGAN PRESERVATION SYSTEMJanuary 2021January 2023Allow2410YesNo
17140057FLOW THROUGH ELECTROPORATION MODULES AND INSTRUMENTATIONJanuary 2021April 2021Allow300NoNo
17131285METHODS FOR CONTROLLING THE GROWTH OF PROKARYOTIC AND EUKARYOTIC CELLSDecember 2020April 2023Abandon2810NoNo
17253080DISPOSABLE BIOREACTOR AND USE THEREOFDecember 2020December 2024Abandon4820NoNo
17118268DIGESTER COMPRISING A DESULFURIZATION NET COMBINED WITH PENDENT ROPESDecember 2020July 2023Abandon3120NoNo
16973168METHOD FOR GASSING BIOREACTORS AND GASSING SYSTEMDecember 2020April 2023Allow2810NoNo
17059716MULTI-LAYER CULTURE VESSEL OBSERVATION SYSTEM, CART DEVICE, AND MULTI-LAYER CULTURE VESSEL OBSERVATION DEVICENovember 2020March 2024Abandon4020YesNo
17100972BIOREACTOR FOR CELL CULTURENovember 2020October 2022Abandon2321YesYes
17054364DEVICE AND METHOD FOR CULTURING CELLS IN A SHAKING OPERATIONNovember 2020March 2023Abandon2820NoNo
17051437CELL CULTURE DEVICE, CELL CULTURE METHOD, AND RECORDING MEDIUMOctober 2020April 2025Allow5321NoNo
17074682BIOPROCESS AND MICROBE ENGINEERING FOR TOTAL CARBON UTILIZATION IN BIOFUEL PRODUCTIONOctober 2020September 2023Allow3510YesNo
17046114TUBULAR CELL STRUCTURE CULTIVATION MAINTAINING APPARATUS AND TUBULAR CELL STRUCTURE MAINTAINING SUPPORT DEVICEOctober 2020April 2024Allow4230YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BEISNER, WILLIAM H.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
3
Examiner Affirmed
2
(66.7%)
Examiner Reversed
1
(33.3%)
Reversal Percentile
49.3%
Lower than average

What This Means

With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
15
Allowed After Appeal Filing
3
(20.0%)
Not Allowed After Appeal Filing
12
(80.0%)
Filing Benefit Percentile
21.6%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BEISNER, WILLIAM H - Prosecution Strategy Guide

Executive Summary

Examiner BEISNER, WILLIAM H works in Art Unit 1799 and has examined 553 patent applications in our dataset. With an allowance rate of 67.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner BEISNER, WILLIAM H's allowance rate of 67.1% places them in the 21% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by BEISNER, WILLIAM H receive 2.08 office actions before reaching final disposition. This places the examiner in the 69% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BEISNER, WILLIAM H is 35 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +27.0% benefit to allowance rate for applications examined by BEISNER, WILLIAM H. This interview benefit is in the 78% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 22.5% of applications are subsequently allowed. This success rate is in the 20% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 53.6% of cases where such amendments are filed. This entry rate is in the 75% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 4% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 62.5% of appeals filed. This is in the 35% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 52.1% are granted (fully or in part). This grant rate is in the 65% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.5% of allowed cases (in the 61% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.9% of allowed cases (in the 78% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.